34
IRUS Total
Downloads
  Altmetric

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

Title: Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
Authors: Ryom, L
Boesecke, C
Bracchi, M
Ambrosioni, J
Pozniak, A
Arribas, J
Behrens, G
Mallon, P
Puoti, M
Rauch, A
Miro, JM
Kirk, O
Marzolini, C
Lundgren, JD
Battegay, M
EACS Governing Board
Item Type: Journal Article
Abstract: BACKGROUND: The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisciplinary recommendations for the care of HIV-positive persons in geographically diverse areas. GUIDELINE HIGHLIGHTS: Major revisions have been made in all sections of the 2017 Guidelines: antiretroviral treatment (ART), comorbidities, coinfections and opportunistic diseases. Newly added are also a summary of the main changes made, and direct video links to the EACS online course on HIV Management. Recommendations on the clinical situations in which tenofovir alafenamide may be considered over tenofovir disoproxil fumarate are provided, and recommendations on which antiretrovirals can be used safely during pregnancy have been revised. Renal and bone toxicity and hepatitis C virus (HCV) treatment have been added as potential reasons for ART switches in fully virologically suppressed individuals, and dolutegravir/rilpivirine has been included as a treatment option. In contrast, dolutegravir monotherapy is not recommended. New recommendations on non-alcoholic fatty liver disease, chronic lung disease, solid organ transplantation, and prescribing in elderly are included, and human papilloma virus (HPV) vaccination recommendations have been expanded. All drug-drug interaction tables have been updated and new tables are included. Treatment options for direct-acting antivirals (DAAs) have been updated and include the latest combinations of sofosbuvir/velpatasvir/voxilaprevir and glecaprevir/pibrentasvir. Recommendations on management of DAA failure and acute HCV infection have been expanded. For treatment of tuberculosis (TB), it is underlined that intermittent treatment is contraindicated, and for resistant TB new data suggest that using a three-drug combination may be as effective as a five-drug regimen, and may reduce treatment duration from 18-24 to 6-10 months. CONCLUSIONS: Version 9.0 of the EACS Guidelines provides a holistic approach to HIV care and is translated into the six most commonly spoken languages.
Issue Date: 1-May-2018
Date of Acceptance: 8-Jan-2018
URI: http://hdl.handle.net/10044/1/73800
DOI: https://doi.org/10.1111/hiv.12600
ISSN: 1464-2662
Publisher: Wiley
Start Page: 309
End Page: 315
Journal / Book Title: HIV Medicine
Volume: 19
Issue: 5
Copyright Statement: © 2018 The Authors. HIV Medicine Published by John Wiley & Sons Ltd on behalf of British HIV Association This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Keywords: ART
European AIDS Clinical Society guidelines
HBV
HCV
HIV
antiretroviral treatment
coinfections
comorbidities
opportunistic diseases
AIDS-Related Opportunistic Infections
Adult
Anti-Retroviral Agents
Antiretroviral Therapy, Highly Active
Coinfection
Drug Interactions
Europe
Female
HIV Infections
Humans
Male
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications, Infectious
Societies, Scientific
EACS Governing Board
Humans
AIDS-Related Opportunistic Infections
Pregnancy Complications, Infectious
HIV Infections
Anti-Retroviral Agents
Antiretroviral Therapy, Highly Active
Pregnancy
Drug Interactions
Adult
Societies, Scientific
Europe
Female
Male
Practice Guidelines as Topic
Coinfection
ART
European AIDS Clinical Society guidelines
HBV
HCV
HIV
antiretroviral treatment
coinfections
comorbidities
opportunistic diseases
AIDS-Related Opportunistic Infections
Adult
Anti-Retroviral Agents
Antiretroviral Therapy, Highly Active
Coinfection
Drug Interactions
Europe
Female
HIV Infections
Humans
Male
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications, Infectious
Societies, Scientific
Virology
1103 Clinical Sciences
Publication Status: Published
Conference Place: England
Online Publication Date: 2018-03-01
Appears in Collections:Department of Infectious Diseases